Drug
Levalbuterol Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Impaired Quality Of Life | 52 | 21.8 | 22.1 | signal |
| 2 | Seasonal Allergy | 42 | 17.9 | 18.1 | signal |
| 3 | Blood Calcium Decreased | 30 | 16.0 | 16.1 | signal |
| 4 | Asthma | 254 | 13.6 | 14.6 | signal |
| 5 | Chronic Obstructive Pulmonary Disease | 111 | 12.8 | 13.2 | signal |
| 6 | Infusion Site Pain | 25 | 11.8 | 11.9 | signal |
| 7 | Orthostatic Hypotension | 34 | 11.7 | 11.8 | signal |
| 8 | Respiratory Tract Infection | 47 | 10.9 | 11.0 | signal |
| 9 | Acute Respiratory Failure | 34 | 10.7 | 10.8 | signal |
| 10 | Vitamin D Deficiency | 17 | 10.5 | 10.5 | signal |
| 11 | Productive Cough | 71 | 9.0 | 9.2 | signal |
| 12 | Sputum Discoloured | 14 | 8.9 | 8.9 | signal |
| 13 | Candida Infection | 23 | 8.3 | 8.3 | signal |
| 14 | Secretion Discharge | 17 | 8.3 | 8.3 | signal |
| 15 | Atelectasis | 12 | 7.4 | 7.5 | signal |
| 16 | Oxygen Saturation Decreased | 69 | 7.4 | 7.6 | signal |
| 17 | Sedation | 32 | 7.4 | 7.4 | signal |
| 18 | Ear Infection | 32 | 7.3 | 7.3 | signal |
| 19 | Laryngitis | 13 | 7.2 | 7.2 | signal |
| 20 | Bronchitis | 89 | 7.2 | 7.4 | signal |
| 21 | Flank Pain | 11 | 7.1 | 7.1 | signal |
| 22 | Upper Respiratory Tract Infection | 54 | 7.0 | 7.1 | signal |
| 23 | Insurance Issue | 17 | 6.9 | 6.9 | signal |
| 24 | Respiratory Tract Congestion | 18 | 6.8 | 6.8 | signal |
| 25 | Sinusitis | 114 | 6.7 | 6.9 | signal |
| 26 | Sinus Congestion | 15 | 6.7 | 6.7 | signal |
| 27 | Loss Of Personal Independence In Daily Activities | 52 | 6.6 | 6.7 | signal |
| 28 | Emphysema | 11 | 6.5 | 6.6 | signal |
| 29 | Oral Candidiasis | 14 | 6.5 | 6.5 | signal |
| 30 | Bronchospasm | 15 | 6.3 | 6.3 | signal |
| 31 | Illness | 105 | 6.3 | 6.4 | signal |
| 32 | End Stage Renal Disease | 19 | 6.2 | 6.2 | signal |
| 33 | Wheezing | 61 | 6.2 | 6.3 | signal |
| 34 | Aphonia | 14 | 6.0 | 6.1 | signal |
| 35 | Iron Deficiency Anaemia | 9 | 5.9 | 5.9 | signal |
| 36 | Dermatitis Contact | 11 | 5.8 | 5.8 | signal |
| 37 | Pneumonia | 313 | 5.8 | 6.3 | signal |
| 38 | Viral Infection | 32 | 5.8 | 5.8 | signal |
| 39 | Brain Fog | 14 | 5.8 | 5.8 | signal |
| 40 | Dyspnoea Exertional | 36 | 5.8 | 5.8 | signal |
| 41 | Pneumothorax | 15 | 5.7 | 5.7 | signal |
| 42 | Haemoptysis | 26 | 5.6 | 5.6 | signal |
| 43 | Dysphonia | 54 | 5.6 | 5.6 | signal |
| 44 | Cough | 249 | 5.4 | 5.7 | signal |
| 45 | Pulmonary Mass | 13 | 5.3 | 5.3 | signal |
| 46 | Sleep Disorder Due To A General Medical Condition | 14 | 5.2 | 5.2 | signal |
| 47 | Impaired Gastric Emptying | 11 | 5.2 | 5.2 | signal |
| 48 | Bacteraemia | 10 | 5.1 | 5.1 | signal |
| 49 | Covid-19 Pneumonia | 10 | 5.1 | 5.1 | signal |
| 50 | Decreased Activity | 9 | 5.0 | 5.1 | signal |
| 51 | Depressed Level Of Consciousness | 33 | 5.0 | 5.1 | signal |
| 52 | Pharyngeal Swelling | 8 | 5.0 | 5.0 | signal |
| 53 | Chronic Kidney Disease | 64 | 5.0 | 5.1 | signal |
| 54 | Wrist Fracture | 10 | 5.0 | 5.0 | signal |
| 55 | Respiratory Distress | 23 | 5.0 | 5.0 | signal |
| 56 | Aspiration | 9 | 5.0 | 5.0 | signal |
| 57 | Oral Herpes | 16 | 4.9 | 5.0 | signal |
| 58 | Sinus Disorder | 16 | 4.9 | 4.9 | signal |
| 59 | Eye Infection | 9 | 4.8 | 4.8 | signal |
| 60 | Hypoxia | 28 | 4.8 | 4.8 | signal |
| 61 | Foot Fracture | 15 | 4.7 | 4.8 | signal |
| 62 | Dyspnoea | 446 | 4.7 | 5.3 | signal |
| 63 | Poor Venous Access | 8 | 4.7 | 4.7 | signal |
| 64 | Lung Disorder | 37 | 4.5 | 4.6 | signal |
| 65 | Musculoskeletal Discomfort | 13 | 4.5 | 4.6 | signal |
| 66 | Tachypnoea | 10 | 4.4 | 4.4 | signal |
| 67 | Small Intestinal Obstruction | 9 | 4.4 | 4.4 | signal |
| 68 | Supraventricular Tachycardia | 7 | 4.4 | 4.4 | signal |
| 69 | Heart Rate Increased | 72 | 4.4 | 4.4 | signal |
| 70 | Device Delivery System Issue | 19 | 4.4 | 4.4 | signal |
| 71 | Throat Irritation | 32 | 4.3 | 4.3 | signal |
| 72 | Sneezing | 16 | 4.3 | 4.3 | signal |
| 73 | Cognitive Disorder | 33 | 4.3 | 4.3 | signal |
| 74 | Bacterial Infection | 13 | 4.2 | 4.2 | signal |
| 75 | Chest Discomfort | 71 | 4.2 | 4.3 | signal |
| 76 | Intentional Dose Omission | 19 | 4.2 | 4.2 | signal |
| 77 | Oropharyngeal Pain | 64 | 4.2 | 4.2 | signal |
| 78 | Ear Discomfort | 7 | 4.1 | 4.1 | signal |
| 79 | Rib Fracture | 14 | 4.1 | 4.1 | signal |
| 80 | Ear Pain | 13 | 4.0 | 4.0 | signal |
| 81 | Covid-19 | 118 | 4.0 | 4.1 | signal |
| 82 | Hereditary Angioedema | 7 | 4.0 | 4.0 | signal |
| 83 | Nasal Congestion | 39 | 4.0 | 4.0 | signal |
| 84 | Leukocytosis | 12 | 4.0 | 4.0 | signal |
| 85 | Osteopenia | 10 | 3.9 | 3.9 | signal |
| 86 | Skin Laceration | 7 | 3.9 | 3.9 | signal |
| 87 | Oral Discomfort | 9 | 3.9 | 3.9 | signal |
| 88 | Pharyngitis Streptococcal | 7 | 3.9 | 3.9 | signal |
| 89 | Clostridium Difficile Infection | 14 | 3.9 | 3.9 | signal |
| 90 | Hepatic Encephalopathy | 6 | 3.9 | 3.9 | signal |
| 91 | Arteriosclerosis | 6 | 3.8 | 3.8 | signal |
| 92 | Renal Injury | 19 | 3.8 | 3.8 | signal |
| 93 | Throat Tightness | 17 | 3.8 | 3.8 | signal |
| 94 | Seizure | 72 | 3.8 | 3.8 | signal |
| 95 | Pulmonary Hypertension | 13 | 3.7 | 3.7 | signal |
| 96 | Respiratory Failure | 45 | 3.7 | 3.7 | signal |
| 97 | Infection | 88 | 3.7 | 3.7 | signal |
| 98 | Influenza | 68 | 3.7 | 3.7 | signal |
| 99 | Ligament Sprain | 6 | 3.7 | 3.7 | signal |
| 100 | Blood Pressure Abnormal | 12 | 3.6 | 3.7 | signal |
| 101 | Hospitalisation | 92 | 3.6 | 3.7 | signal |
| 102 | Respiratory Disorder | 18 | 3.6 | 3.6 | signal |
| 103 | Gastrooesophageal Reflux Disease | 48 | 3.6 | 3.6 | signal |
| 104 | Hypoaesthesia Oral | 9 | 3.6 | 3.6 | signal |
| 105 | Balance Disorder | 51 | 3.5 | 3.6 | signal |
| 106 | Initial Insomnia | 6 | 3.5 | 3.5 | signal |
| 107 | Adrenal Insufficiency | 7 | 3.5 | 3.5 | signal |
| 108 | Spinal Operation | 7 | 3.5 | 3.5 | signal |
| 109 | Product Odour Abnormal | 6 | 3.5 | 3.5 | signal |
| 110 | Feeling Jittery | 11 | 3.5 | 3.5 | signal |
| 111 | Weight Fluctuation | 6 | 3.5 | 3.5 | signal |
| 112 | Tenderness | 6 | 3.5 | 3.5 | signal |
| 113 | Fungal Infection | 19 | 3.4 | 3.4 | signal |
| 114 | Paraesthesia Oral | 8 | 3.3 | 3.4 | signal |
| 115 | Body Height Decreased | 6 | 3.3 | 3.3 | signal |
| 116 | Gastroenteritis Viral | 10 | 3.3 | 3.3 | signal |
| 117 | Therapeutic Product Effect Incomplete | 39 | 3.3 | 3.3 | signal |
| 118 | Upper Limb Fracture | 11 | 3.3 | 3.3 | signal |
| 119 | Pulmonary Thrombosis | 6 | 3.3 | 3.3 | signal |
| 120 | Pulmonary Arterial Hypertension | 8 | 3.3 | 3.3 | signal |
| 121 | Eye Pruritus | 18 | 3.3 | 3.3 | signal |
| 122 | Immunodeficiency | 8 | 3.3 | 3.3 | signal |
| 123 | Incorrect Product Administration Duration | 11 | 3.3 | 3.3 | signal |
| 124 | Fluid Overload | 8 | 3.3 | 3.3 | signal |
| 125 | Dry Eye | 26 | 3.2 | 3.2 | signal |
| 126 | Product Taste Abnormal | 7 | 3.1 | 3.1 | signal |
| 127 | Mobility Decreased | 37 | 3.1 | 3.1 | signal |
| 128 | Musculoskeletal Chest Pain | 8 | 3.1 | 3.1 | signal |
| 129 | Product Dose Omission Issue | 147 | 3.1 | 3.2 | signal |
| 130 | Choking | 10 | 3.1 | 3.1 | signal |
| 131 | Fluid Retention | 26 | 3.1 | 3.1 | signal |
| 132 | Anaphylactic Reaction | 28 | 3.1 | 3.1 | signal |
| 133 | Blood Iron Decreased | 6 | 3.1 | 3.1 | signal |
| 134 | Inability To Afford Medication | 5 | 3.1 | 3.1 | signal |
| 135 | Macular Degeneration | 6 | 3.0 | 3.0 | signal |
| 136 | Bladder Disorder | 5 | 3.0 | 3.0 | signal |
| 137 | Salivary Hypersecretion | 5 | 3.0 | 3.0 | signal |
| 138 | Brain Injury | 5 | 3.0 | 3.0 | signal |
| 139 | Epistaxis | 37 | 3.0 | 3.0 | signal |
| 140 | Eyelid Ptosis | 5 | 3.0 | 3.0 | signal |
| 141 | Temperature Intolerance | 5 | 2.9 | 2.9 | signal |
| 142 | Eye Discharge | 5 | 2.9 | 2.9 | signal |
| 143 | Petechiae | 5 | 2.9 | 2.9 | signal |
| 144 | Limb Injury | 13 | 2.9 | 2.9 | signal |
| 145 | Transfusion | 5 | 2.9 | 2.9 | signal |
| 146 | Head Injury | 15 | 2.9 | 2.9 | signal |
| 147 | Electrocardiogram Qt Prolonged | 17 | 2.8 | 2.8 | signal |
| 148 | Lower Limb Fracture | 9 | 2.8 | 2.8 | signal |
| 149 | Retching | 10 | 2.8 | 2.8 | signal |
| 150 | Joint Injury | 10 | 2.8 | 2.8 | signal |
| 151 | Scar | 8 | 2.8 | 2.8 | signal |
| 152 | Therapy Interrupted | 32 | 2.8 | 2.8 | signal |
| 153 | Kidney Infection | 9 | 2.8 | 2.8 | signal |
| 154 | Cardiac Failure Congestive | 37 | 2.7 | 2.8 | signal |
| 155 | Complication Associated With Device | 6 | 2.7 | 2.7 | signal |
| 156 | Palpitations | 53 | 2.7 | 2.7 | signal |
| 157 | Spinal Fracture | 9 | 2.7 | 2.7 | signal |
| 158 | Lung Infection | 7 | 2.7 | 2.7 | signal |
| 159 | Migraine | 42 | 2.7 | 2.7 | signal |
| 160 | Status Epilepticus | 5 | 2.7 | 2.7 | no signal |
| 161 | Diverticulitis | 12 | 2.6 | 2.6 | signal |
| 162 | Nerve Compression | 4 | 2.6 | 2.6 | no signal |
| 163 | Knee Arthroplasty | 9 | 2.6 | 2.6 | signal |
| 164 | Product Packaging Issue | 4 | 2.6 | 2.6 | no signal |
| 165 | Multiple Fractures | 7 | 2.5 | 2.5 | signal |
| 166 | Localised Infection | 10 | 2.5 | 2.5 | signal |
| 167 | Nasopharyngitis | 75 | 2.4 | 2.5 | signal |
| 168 | Exposure Via Skin Contact | 9 | 2.4 | 2.4 | signal |
| 169 | Procedural Pain | 11 | 2.4 | 2.4 | signal |
| 170 | Dementia | 11 | 2.4 | 2.4 | signal |
| 171 | Sluggishness | 4 | 2.4 | 2.4 | no signal |
| 172 | Product Use Complaint | 6 | 2.3 | 2.3 | no signal |
| 173 | Inappropriate Schedule Of Product Administration | 68 | 2.3 | 2.3 | signal |
| 174 | Anhedonia | 10 | 2.3 | 2.3 | signal |
| 175 | Product Dose Omission In Error | 10 | 2.2 | 2.2 | signal |
| 176 | Pneumonitis | 10 | 2.2 | 2.2 | signal |
| 177 | Product Packaging Quantity Issue | 4 | 2.2 | 2.2 | no signal |
| 178 | Dry Skin | 48 | 2.2 | 2.2 | signal |
| 179 | Eye Irritation | 20 | 2.2 | 2.2 | signal |
| 180 | Blindness Unilateral | 5 | 2.1 | 2.1 | no signal |
| 181 | Internal Haemorrhage | 4 | 2.1 | 2.1 | no signal |
| 182 | Therapeutic Response Shortened | 11 | 2.1 | 2.1 | signal |
| 183 | Surgery | 20 | 2.1 | 2.1 | signal |
| 184 | Gastrointestinal Haemorrhage | 29 | 2.1 | 2.1 | signal |
| 185 | Unevaluable Event | 25 | 2.0 | 2.0 | no signal |
| 186 | Cardiac Disorder | 31 | 2.0 | 2.0 | no signal |
| 187 | Pelvic Pain | 6 | 2.0 | 2.0 | no signal |
| 188 | Respiratory Depression | 4 | 2.0 | 2.0 | no signal |
| 189 | Dermatitis Atopic | 16 | 1.9 | 1.9 | no signal |
| 190 | Eye Inflammation | 3 | 1.9 | 1.9 | no signal |
| 191 | Needle Issue | 9 | 1.9 | 1.9 | no signal |
| 192 | Intraocular Pressure Increased | 4 | 1.9 | 1.9 | no signal |
| 193 | Decreased Immune Responsiveness | 3 | 1.8 | 1.8 | no signal |
| 194 | Product Substitution Issue | 17 | 1.8 | 1.8 | no signal |
| 195 | Product Prescribing Issue | 6 | 1.8 | 1.8 | no signal |
| 196 | Mood Altered | 8 | 1.8 | 1.8 | no signal |
| 197 | Coronary Artery Occlusion | 4 | 1.7 | 1.7 | no signal |
| 198 | Device Use Issue | 5 | 1.7 | 1.7 | no signal |
| 199 | Neurotoxicity | 5 | 1.7 | 1.7 | no signal |
| 200 | Expired Product Administered | 9 | 1.6 | 1.6 | no signal |
| 201 | Device Malfunction | 17 | 1.5 | 1.5 | no signal |
| 202 | Product Physical Issue | 5 | 1.5 | 1.5 | no signal |
| 203 | Lung Neoplasm Malignant | 10 | 1.5 | 1.5 | no signal |
| 204 | Product Dose Omission | 16 | 1.5 | 1.5 | no signal |
| 205 | Circumstance Or Information Capable Of Leading To Medication Error | 8 | 1.4 | 1.4 | no signal |
| 206 | Injection Site Rash | 7 | 1.4 | 1.4 | no signal |
| 207 | Product Dispensing Error | 5 | 1.4 | 1.4 | no signal |
| 208 | Psoriatic Arthropathy | 9 | 1.3 | 1.3 | no signal |
| 209 | Injection Site Mass | 8 | 1.3 | 1.3 | no signal |
| 210 | Skin Burning Sensation | 15 | 1.3 | 1.3 | no signal |
| 211 | Pancreatic Carcinoma | 6 | 1.2 | 1.2 | no signal |
| 212 | Accidental Underdose | 3 | 1.2 | 1.2 | no signal |
| 213 | Plasma Cell Myeloma | 8 | 1.2 | 1.2 | no signal |
| 214 | Device Failure | 3 | 1.2 | 1.2 | no signal |
| 215 | Acne | 15 | 1.2 | 1.2 | no signal |
| 216 | Product Storage Error | 17 | 1.2 | 1.2 | no signal |
| 217 | Drug Dose Omission By Device | 15 | 1.2 | 1.2 | no signal |
| 218 | Injection Site Warmth | 4 | 1.2 | 1.2 | no signal |
| 219 | Product Quality Issue | 26 | 1.2 | 1.2 | no signal |
| 220 | Injection Site Reaction | 12 | 1.1 | 1.1 | no signal |
| 221 | Injection Site Pain | 53 | 1.0 | 1.0 | no signal |
| 222 | Device Issue | 15 | 1.0 | 1.0 | no signal |
| 223 | Injection Site Swelling | 13 | 1.0 | 1.0 | no signal |
| 224 | Syringe Issue | 3 | 1.0 | 1.0 | no signal |
| 225 | Drug Abuse | 14 | 1.0 | 1.0 | no signal |
| 226 | Product Complaint | 4 | 1.0 | 1.0 | no signal |
| 227 | Injection Site Bruising | 11 | 0.8 | 0.8 | no signal |
| 228 | Injection Site Pruritus | 9 | 0.8 | 0.8 | no signal |
| 229 | Device Breakage | 5 | 0.8 | 0.8 | no signal |
| 230 | Accidental Exposure To Product | 12 | 0.7 | 0.7 | no signal |
| 231 | Device Leakage | 5 | 0.7 | 0.7 | no signal |
| 232 | Device Use Error | 4 | 0.7 | 0.7 | no signal |
| 233 | Breast Cancer Female | 3 | 0.7 | 0.7 | no signal |
| 234 | Wrong Technique In Device Usage Process | 5 | 0.7 | 0.7 | no signal |
| 235 | Bladder Cancer | 3 | 0.3 | 0.3 | no signal |